Trust Company of the Ozarks’s Novartis NVS Stock Holding History

Trust Company of the Ozarks’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.04M	Sell	12,582 -418	-3%	-$37.2K	0.36%	64
2015 Q2	$1.15M	Sell	13,000 -670	-5%	-$61.5K	0.32%	62
2015 Q1	$1.21M	Sell	13,670 -1,515	-10%	-$134K	0.32%	57
2014 Q4	$1.26M	Sell	15,185 -170	-1%	-$14.1K	0.35%	55
2014 Q3	$1.29M	Buy	15,355 +377	+3%	+$30.5K	0.36%	54
2014 Q2	$1.22M	Sell	14,978 -781	-5%	-$61.4K	0.33%	55
2014 Q1	$1.2M	Sell	15,759 -275	-2%	-$20K	0.34%	54
2013 Q4	$1.16M	Buy	16,034 +547	+4%	+$38K	0.33%	55
2013 Q3	$1.06M	Sell	15,487 -111	-0.7%	-$7.34K	0.33%	54
2013 Q2	$989K	Buy	+15,598	New	+$1.01M	0.33%	57

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.51% 1-Year Est. Return

Trust Company of the Ozarks's NVS Position: Q3 2015 in Review

Trust Company of the Ozarks reduced its Novartis (NVS) stake by 3.2% in Q3 2015, selling an estimated $37.2K and leaving 12,582 shares worth $1.04M. The position accounts for 0.36% of the portfolio, ranked #64.

Trust Company of the Ozarks first reported a position in NVS in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.29M in Q3 2014. 926 funds tracked by Wall St. Rank hold NVS as of Q3 2015.

Trust Company of the Ozarks held 12,582 shares of Novartis worth $1.04M as of Q3 2015.
Trust Company of the Ozarks sold 418 Novartis shares in Q3 2015, an estimated $37.2K.
Novartis made up 0.36% of Trust Company of the Ozarks's portfolio in Q3 2015, its #64 holding.
Trust Company of the Ozarks first reported a position in Novartis in Q2 2013 and has held it in 10 quarters since.
Trust Company of the Ozarks's Novartis position peaked at $1.29M in Q3 2014.
926 funds tracked by Wall St. Rank held Novartis as of Q3 2015.

Based on Trust Company of the Ozarks's 13F filing for Q3 2015, filed 4 Nov 2015.